TuHURA Biosciences (HURA) Change in Account Payables (2010 - 2024)
TuHURA Biosciences' (HURA) quarterly Change in Account Payables came in at -$4000.0 in Q3 2024, down 110.0% year-on-year from $40000.0 in Q4 2023, and up 98.0% quarter-over-quarter from -$200000.0 in Q1 2024.
TuHURA Biosciences (HURA) Change in Account Payables (2010 - 2024) Analysis & Trends
TuHURA Biosciences' Change in Account Payables history runs 15 years deep, the most recent figure standing at -$4000.0 for Q3 2024.
- On a quarterly basis, Change in Account Payables fell 110.0% year-over-year to -$4000.0 in Q3 2024; TTM through Sep 2024 was -$314000.0, a 54.43% increase from a year earlier, with the FY2024 full-year figure at -$248000.0, up 41.37% from the prior year.
- Change in Account Payables advanced to -$4000.0 in Q3 2024 per HURA's latest filing, from -$200000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $368000.0 in Q2 2020 and bottomed at -$368000.0 in Q1 2023.
- The 5-year median for Change in Account Payables is -$70000.0 (2021), against an average of -$35176.5.
- Across the five-year window, Change in Account Payables jumped 375.0% in 2021 and plunged 509.62% in 2022, its largest moves.
- Year by year, Change in Account Payables stood at -$92000.0 in 2020, then surged by 156.52% to $52000.0 in 2021, then plunged by 509.62% to -$213000.0 in 2022, then advanced by 29.58% to -$150000.0 in 2023, then soared by 97.33% to -$4000.0 in 2024.
- Per Business Quant, the three latest HURA Change in Account Payables figures stand at -$4000.0 (Q3 2024), -$200000.0 (Q1 2024), and -$150000.0 (Q4 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 16.86 Mn |
| 10 | TuHURA Biosciences | 132.62 Mn | 132.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -4,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Mar 31, 2024 | -200,000.00 |
| Mar 31, 2024 | -200,000.00 |
| Dec 31, 2023 | -150,000.00 |
| Dec 31, 2023 | -150,000.00 |
| Sep 30, 2023 | 40,000.00 |
| Sep 30, 2023 | 40,000.00 |
| Mar 31, 2023 | -368,000.00 |
| Mar 31, 2023 | -368,000.00 |
| Dec 31, 2022 | -213,000.00 |
| Dec 31, 2022 | -213,000.00 |
| Sep 30, 2022 | -148,000.00 |
| Sep 30, 2022 | -148,000.00 |
| Jun 30, 2022 | 263,000.00 |
| Jun 30, 2022 | 263,000.00 |
| Mar 31, 2022 | -85,000.00 |
| Mar 31, 2022 | -85,000.00 |
| Dec 31, 2021 | 52,000.00 |
| Dec 31, 2021 | 52,000.00 |